Platinum-based Chemotherapy With Atezolizumab and Niraparib in Patients With Recurrent Ovarian Cancer

NCT03598270 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

417

Enrollment

OTHER

Sponsor class

Conditions

Recurrent Ovarian Carcinoma

Interventions

DRUG: Placebo
DRUG: Carboplatin
DRUG: Paclitaxel
DRUG: Niraparib
DRUG: Gemcitabine
DRUG: Pegylated liposomal doxorubicin (PLD)
DRUG: Atezolizumab

Sponsor

Grupo Español de Investigación en Cáncer de Ovario

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]